See more : Wuhan Keqian Biology Co.,Ltd (688526.SS) Income Statement Analysis – Financial Results
Complete financial analysis of CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CSPC Innovation Pharmaceutical Co., Ltd., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Koil Energy Solutions, Inc. (DPDW) Income Statement Analysis – Financial Results
- Capacit’e Infraprojects Limited (CAPACITE.BO) Income Statement Analysis – Financial Results
- Nishimatsuya Chain Co., Ltd. (7545.T) Income Statement Analysis – Financial Results
- NeuBase Therapeutics, Inc. (NBSE) Income Statement Analysis – Financial Results
- Solomon Worldwide Holdings Limited (8133.HK) Income Statement Analysis – Financial Results
CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ)
About CSPC Innovation Pharmaceutical Co., Ltd.
CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.50B | 2.63B | 1.43B | 1.32B | 1.26B | 1.24B | 1.03B | 890.48M | 742.01M | 650.72M |
| Cost of Revenue | 1.37B | 1.49B | 746.12M | 584.20M | 611.84M | 631.37M | 527.20M | 470.05M | 458.22M | 397.86M |
| Gross Profit | 1.13B | 1.13B | 685.87M | 733.22M | 644.66M | 608.73M | 503.98M | 420.42M | 283.79M | 252.86M |
| Gross Profit Ratio | 45.33% | 43.21% | 47.90% | 55.66% | 51.31% | 49.09% | 48.87% | 47.21% | 38.25% | 38.86% |
| Research & Development | 46.54M | 46.30M | 20.40M | 14.05M | 13.05M | 11.25M | 8.51M | 9.53M | 26.51M | 26.79M |
| General & Administrative | 44.22M | 18.18M | 12.17M | 11.15M | 12.98M | 13.39M | 8.07M | 4.31M | 32.64M | 33.15M |
| Selling & Marketing | 142.43M | 244.25M | 261.00M | 328.04M | 279.07M | 275.52M | 207.36M | 154.47M | 112.09M | 87.99M |
| SG&A | 186.65M | 262.43M | 273.17M | 339.19M | 292.05M | 288.91M | 215.43M | 158.78M | 144.73M | 121.14M |
| Other Expenses | 9.51M | -4.22M | -8.16M | 5.20M | 2.34M | 845.85K | -1.86M | 447.31K | 1.12M | 2.32M |
| Operating Expenses | 241.39M | 375.23M | 322.28M | 390.48M | 340.25M | 333.35M | 255.50M | 201.07M | 152.11M | 126.58M |
| Cost & Expenses | 1.61B | 1.87B | 1.07B | 974.68M | 952.10M | 964.72M | 782.70M | 671.12M | 610.33M | 524.44M |
| Interest Income | 65.90M | 32.75M | 27.30M | 8.59M | 2.43M | 634.42K | 615.12K | 764.27K | 0.00 | 403.50K |
| Interest Expense | 639.77K | 219.23K | 58.60K | 420.54K | 1.50M | 3.39M | 3.27M | 3.24M | 0.00 | 0.00 |
| Depreciation & Amortization | 100.10M | 72.94M | 69.15M | 53.42M | 47.14M | 43.03M | 35.26M | 28.06M | 25.31M | 21.10M |
| EBITDA | 979.94M | 915.19M | 543.12M | 414.67M | 384.04M | 324.34M | 277.49M | 279.54M | 156.99M | 147.38M |
| EBITDA Ratio | 39.17% | 35.49% | 31.07% | 31.52% | 30.19% | 26.42% | 27.00% | 29.61% | 21.16% | 22.67% |
| Operating Income | 891.35M | 855.59M | 395.26M | 360.02M | 332.83M | 276.86M | 240.71M | 247.72M | 135.77M | 124.90M |
| Operating Income Ratio | 35.63% | 32.58% | 27.60% | 27.33% | 26.49% | 22.33% | 23.34% | 27.82% | 18.30% | 19.19% |
| Total Other Income/Expenses | 440.62K | -4.22M | -16.69M | 5.20M | 2.34M | 845.85K | -1.86M | 447.31K | 1.12M | 2.18M |
| Income Before Tax | 891.79M | 851.37M | 387.10M | 365.22M | 335.17M | 277.71M | 238.84M | 248.17M | 136.89M | 127.08M |
| Income Before Tax Ratio | 35.65% | 32.41% | 27.03% | 27.72% | 26.67% | 22.39% | 23.16% | 27.87% | 18.45% | 19.53% |
| Income Tax Expense | 136.47M | 124.76M | 70.55M | 65.51M | 61.64M | 53.38M | 43.93M | 41.82M | 21.40M | 18.84M |
| Net Income | 755.56M | 726.28M | 393.23M | 299.84M | 273.20M | 223.84M | 194.91M | 206.58M | 115.59M | 108.24M |
| Net Income Ratio | 30.20% | 27.65% | 27.46% | 22.76% | 21.74% | 18.05% | 18.90% | 23.20% | 15.58% | 16.63% |
| EPS | 0.65 | 0.65 | 0.40 | 0.31 | 0.28 | 0.30 | 0.26 | 0.28 | 0.16 | 0.09 |
| EPS Diluted | 0.65 | 0.65 | 0.40 | 0.31 | 0.28 | 0.30 | 0.26 | 0.28 | 0.16 | 0.09 |
| Weighted Avg Shares Out | 1.17B | 1.11B | 982.80M | 982.80M | 982.80M | 738.22M | 736.76M | 735.59M | 885.07M | 1.18B |
| Weighted Avg Shares Out (Dil) | 1.17B | 1.11B | 982.80M | 982.80M | 982.80M | 738.22M | 736.76M | 735.59M | 885.07M | 1.18B |
Source: https://incomestatements.info
Category: Stock Reports